Antioestradiol serum (anti-E2) inhibited the uterine weight increases caused by hcg in immature mice and rats (Ferin, Zimmering, Lieberman & Vande Wiele, 1968 
antigen in 1 ml saline with 1 ml adjuvant was used. Up to 40 ml blood were obtained under a mild vacuum at each bleeding from the marginal ear vein.
The anti-BSA portion was absorbed with BSA, the end-point being deter¬ mined with anti-BSA produced in a ram. There appeared to be no real differ¬ ences between the turkey and rabbit antisera. Precipitin titres were at least 1:1000.
Forty-two immature female hamsters were randomly assigned to seven treatment groups (six hamsters per group), as shown in Table 1 (reconstituted) were injected 2 hr before the hcg injection, the uterine weight increases due to hcg were negated (159-7 mg versus 78-9 and 83-3 mg, respectively). The ovarian weight of 29-3 mg for the average of the control and NS-treated hamsters was increased to 33-1 mg for the average of the hcg and hcg plus NS-treated hamsters, but decreased to 26-2 mg for the average of the 3 and 6 mg anti-E2-treated hamsters.
The analysis of covariance for uterine weights (adjusted to constant body weight) showed a highly significant treatment difference (P<0-01) and a highly significant regression (i.e. much of within-treatment differences was explained by the regression of uterine weight on body weight; P<0-01). Ovarian weight differences were not statistically significant. Results indicate that anti-E2 effectively negates the uterine weight increases elicited by hcg in immature hamsters.
The oestradiol-17 ß-succinyl-BSA was kindly supplied by the National Cancer Institute, NIH, Bethesda, Maryland.
